EVOGENE LTD

Historical 13F Holders

Symbol
EVGN
CUSIP
M4119S187
All holders as of
Q2 2026
Type
Equity
Class
SHS NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for M4119S187 since 12/18/2024, newest first.

Filer % of Class Filed
L.I.A. Pure Capital Ltd 13D/A Amendment 7
16.9% 10/6/2026
Event 10/6/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 6
19.4% 9/11/2026
Event 9/8/2026
Recanati Leon 13D/A Amendment 2 8.6% 9/11/2026
Event 8/4/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 5
19.4% 8/28/2026
Event 8/28/2026
Armistice Capital, LLC 13G/A Amendment 1
4.99% 8/14/2026
Event 6/30/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 4
19.4% 8/13/2026
Event 8/10/2026
Recanati Leon 13D/A Amendment 1 8.6% 8/13/2026
Event 8/11/2026
Recanati Leon 13D 5.7% 8/11/2026
Event 8/4/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 3
16.0% 8/7/2026
Event 8/6/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 2
17.4% 7/27/2026
Event 7/26/2026
L.I.A. Pure Capital Ltd 13D/A Amendment 1
16.8% 7/20/2026
Event 7/16/2026
L.I.A. Pure Capital Ltd 13D
12.6% 7/10/2026
Event 7/10/2026
Armistice Capital, LLC 13G
10.0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 14 282 k $120 k
2026 Q1 16 531 k $409 k
2025 Q4 19 182 k $200 k
2025 Q3 15 154 k $176 k
2025 Q2 19 130 k $167 k
2025 Q1 18 421 k $527 k
2024 Q4 18 402 k $752 k
2024 Q3 17 553 k $1.70 M